entertainment -WSS

entertainment

author：Wikipedia 2025-08-31 02:03:03 - browse：5

Scientist walks up a strand of DNA -- First Opinion coverage from STAT — Adobe

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease.

The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players. It also provides Beam, which announced on Oct. 19 that it would cut 100 jobs, or 20% of its workforce, to save cash, a large infusion of money.

“This is like a true win-win-win deal, which is rare in this business, but it’s really, really exciting to see,” said John Evans, Beam’s CEO, in an interview with STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Amylyx ALS drug fails large clinical trial

hotspot

WSS

Parkland mass shooting to be reenacted for lawsuit

NEJM study link tiny plastics in blood vessels to heart problems

Does Medicare's free annual wellness visit do any good?

New company forms to vet health AI models, root out weaknesses

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Sen. Paul opposes bill to ban Chinese biotechs

hotspot

entertainment

entertainment

New air purifier tech could be key to improving indoor air quality

NEJM study link tiny plastics in blood vessels to heart problems

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

23andMe had bad news about my health. I wish a person had delivered it

'Cuddling' is just what the doctor ordered for a 200

Walensky prepares to leave CDC — and Congress — behind

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Wikipedia

Medical mystery: When an infection after surgery isn’t what it seems

First medicine developed to treat MASH expected to be approved soon

UnitedHealth quietly bought dozens of outpatient centers

Parkland mass shooting to be reenacted for lawsuit

What it’s like to watch children die of measles

A deep dive into Applied Therapeutics’ data, and questions on Cassava

hotspot

hotspot

leisure time

knowledge